Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 14(1): 20542, 2024 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-39232118

RESUMEN

In this study, we calculate the Higgs mass matrix and explore the limitations of the minimum conditions of the scalar potential on parameter degrees of freedom in the CP violation TNMSSM. We discuss the contributions of some parameters to Higgs mass, and their impact on the strength of Higgs decay signals in different decay channels h → γ γ , h → VV ( V = W , Z ) and h → f f ¯ ( f = b , c , τ ) .

2.
Comput Biol Med ; 58: 110-7, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25637777

RESUMEN

BACKGROUND: Tuberculosis remains one of the deadliest infectious diseases in humans. It has caused more than 100 million deaths since its discovery in 1882. Currently, more than 5 million people are infected with TB bacterium each year. The cell wall of Mycobacterium tuberculosis plays an important role in maintaining the ability of mycobacteria to survive in a hostile environment. Therefore, we report a virtual screening (VS) study aiming to identify novel inhibitors that simultaneously target RmlB and RmlC, which are two essential enzymes for the synthesis of the cell wall of M. tuberculosis. METHODS: A hybrid VS method that combines drug-likeness prediction, pharmacophore modeling and molecular docking studies was used to indentify inhibitors targeting RmlB and RmlC. RESULTS: The pharmacophore models HypoB and HypoC of RmlB inhibitors and RmlC inhibitors, respectively, were developed based on ligands complexing with their corresponding receptors. In total, 20 compounds with good absorption, distribution, metabolism, excretion, and toxicity properties were carefully selected using the hybird VS method. DISCUSSION: We have established a hybrid VS method to discover novel inhibitors with new scaffolds. The molecular interactions of the selected potential inhibitors with the active-site residues are discussed in detail. These compounds will be further evaluated using biological activity assays and deserve consideration for further structure-activity relationship studies.


Asunto(s)
Antituberculosos/química , Proteínas Bacterianas/antagonistas & inhibidores , Carbohidrato Epimerasas/antagonistas & inhibidores , Pared Celular/efectos de los fármacos , Descubrimiento de Drogas/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Antituberculosos/metabolismo , Antituberculosos/farmacología , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Carbohidrato Epimerasas/química , Carbohidrato Epimerasas/metabolismo , Pared Celular/metabolismo , Simulación del Acoplamiento Molecular , Mycobacterium tuberculosis/citología , Conformación Proteica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA